Roland M Evans

Title: Roland M. Evans: Innovator in Recombinant Protein Production

Introduction

Roland M. Evans, based in La Jolla, California, is an accomplished inventor known for his significant contributions to biotechnological innovations. With a focus on the production of recombinant proteins, Evans has shaped methods that advance biopharmaceutical research and development.

Latest Patents

Evans holds a patent for "Controlled expression of recombinant proteins." This innovative patent outlines methods for the controlled production of recombinant proteins within cells. The technology hinges on a gene encoding the desired protein, regulated by a transcriptional control element activated by a ligand/receptor complex. Notably, this complex is created when a ligand, such as a hormone or its analog, binds to a suitable receptor that has transcription-activating properties. This enhances the production efficiency and potential application of these proteins in various medical and research contexts.

Career Highlights

Roland M. Evans has established himself at the Salk Institute for Biological Studies, a prominent research institution renowned for its work in biological sciences. His role there has allowed him to make substantial strides in the understanding and manipulation of gene expression, particularly through recombinant DNA technology.

Collaborations

Throughout his career, Evans has collaborated with distinguished peers, including Cary Alan Weinberger and Stanley M. Hollenberg. These collaborations have fostered an environment of shared knowledge and innovation, further propelling research in the field of protein expression and genetic regulation.

Conclusion

In summary, Roland M. Evans stands out as a significant figure in the realm of biotechnological innovation, particularly for his patent that enhances the production of recombinant proteins. His work at the Salk Institute and collaborations with esteemed colleagues continue to influence the future of genetic research and therapeutic development.